With the analysis among 109 patents, we discovered top 11 key players by total patent application. Mirati Therapeutics, Inc., Novartis AG, Fulcrum Therapeutics, Inc. are dominant in this area. They take 66.06% of the total patent filing.
California, United States
Patent: 31
Basel-Stadt, Switzerland
Patent: 27
Massachusetts, United States
Patent: 14
Jiangsu Sheng, China
Patent: 3
California, United States
Patent: 2
Massachusetts, United States
Patent: 2
Sichuan Sheng, China
Patent: 1
Massachusetts, United States
Patent: 1
Qingyu Pharmaceutical R&D (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 1
No data, please try another search term
With the analysis among related 106 patents applied in the last 5 years. We discover 21 most active companies in this area. The fast-growing Mirati Therapeutics, Inc., Novartis AG, Fulcrum Therapeutics, Inc. take 55.66% of patent filing during this period.
California, United States
Patent: 31
Basel-Stadt, Switzerland
Patent: 14
Massachusetts, United States
Patent: 14
New South Wales, Australia
Patent: 4
Shanghai Shi, China
Patent: 3
Jiangsu Sheng, China
Patent: 3
Tennessee, United States
Patent: 2
With the analysis among related 106 patents in last 5 years, we discover 19 new entrants. Mirati Therapeutics, Inc., Fulcrum Therapeutics, Inc., Shanghai Blueray Biopharma Co.,Ltd. are the most active new entrants in this area.
California, United States
Patent: 31
Massachusetts, United States
Patent: 14
New South Wales, Australia
Patent: 4
Jiangsu Sheng, China
Patent: 3
Tennessee, United States
Patent: 2
Texas, United States
Patent: 2
With the analysis among 17 patents, we discovered top 4 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, Texas A&M University, The Rockefeller University are dominant in this area. They take 70.59% of the total patent filing.
Shanghai Shi, China
Patent: 4
Texas, United States
Patent: 2
New York, United States
Patent: 1